Human chorionic gonadotropin: does it affect human endometrial morphology in vivo?

Area of Science:

• Reproductive Endocrinology
• Gynecology
• Infertility Research

Background:

• Human chorionic gonadotropin (hCG) is a standard ovulation trigger in controlled ovarian hyperstimulation (COH).
• hCG's distinct half-life from luteinizing hormone (LH) suggests potential unique endometrial actions.
• Endometrial hCG/LH receptors may mediate direct effects independent of ovarian hormones.

Purpose of the Study:

• To review the clinical evidence for direct endometrial effects of hCG administration.
• To evaluate the hypothesis that hCG influences endometrial receptivity and histology in vivo.
• To consider the clinical implications of hCG's direct endometrial actions in infertility treatments.

Main Methods:

• Review of existing clinical and experimental data on gonadotropin and hCG effects on the endometrium.
• Discussion of in vitro studies demonstrating decidualization of endometrial stromal cells by hCG.
• Clinical perspective on the in vivo relevance of hCG's endometrial interactions.

Main Results:

• Evidence suggests hCG can directly influence endometrial stromal cell decidualization in vitro.
• Preliminary findings indicate potential in vivo endometrial effects of hCG administration.
• The differing pharmacokinetics of hCG compared to endogenous LH may alter endometrial receptivity.

Conclusions:

• hCG administration in infertility treatments may exert direct effects on endometrial histology.
• These direct endometrial effects of hCG could play a role in luteal phase transformations.
• Endometrial receptivity assessments in COH should consider the direct impact of hCG.